• Home
  • Symeres
  • Formulation Development and Clinical Manufacturing

Formulation Development and Clinical Manufacturing

Formulation Development and Clinical Manufacturing
Product Description

We blend the art of formulation with advanced scientific tools to support drug product development from early stages through Phase 3, offering comprehensive manufacturing and regulatory services. It is often said that formulation is an art, not a science. Our art is supported by an extensive array of scientific tools that allow us to design and deliver formulations across a wide range of modalities, including immediate release, delayed release, extended release, osmotic/pulsatile drug delivery, sprinkle formulation, solution/suspension, and topical formulation. We support projects from toxicology through Phase 3 and beyond, including tech transfer to your commercial site. We can also assist in troubleshooting commercial formulation problems. Our state-of-the-art analytical services encompass method development, verification, and transfer. With cutting-edge equipment such as the Xcelodose X600S for precision capsule filling, the ACG Quest FB II for fluid bed processing, and a range of analytical instruments including automated hardness testers, disintegration apparatus, and moisture analyzers, we ensure unparalleled precision and efficiency at every step of the formulation process. We offer IND enabling, preclinical formulation, solid-state characterization, clinical formulation development, ICH stability studies, dissolution method development, and GMP-compliant clinical manufacturing. Additionally, we provide consultancy and authoring, as well as the review of the CMC technical elements of regulatory dossiers.

Read more Show less

Symeres

  • Country/Region:
    Netherlands
  • On CPHI since:
    2021
  • Certificates:
    3
  • Employees:
    500 - 999
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Primary activities
Contract Research Organisation
View company profile

Symeres

  • Country/Region:
    Netherlands
  • On CPHI since:
    2021
  • Certificates:
    3
  • Employees:
    500 - 999
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Primary activities
Contract Research Organisation
View company profile

More Products from Symeres (6)

  • GMP Manufacturing

    Product GMP Manufacturing

    Close collaboration with our experienced process engineers aid our efforts achieve right first time scale-up of processes for GMP manufacture. The processes developed at our facilities are adapted to the plant environment in close collaboration with experienced process engineers. The limits of operating c...
  • Non-GMP scale-up for IND-enabling studies

    Product Non-GMP scale-up for IND-enabling studies

    Symeres has long-established expertise in non-GMP scale-up for IND-enabling studies, ensuring that our clients can confidently navigate the transition from laboratory-scale synthesis to clinical phases while minimizing costs and risks. The well-documented processes we provide significantly reduce the inh...
  • Route Scouting for challenging APIs

    Product Route Scouting for challenging APIs

    Symeres is well equipped to ideate around your challenging small molecule APIs
  • Solid-State Chemistry and Pre-Formulation Research

    Product Solid-State Chemistry and Pre-Formulation Research

    Our Solid-State experts can help you to selectively crystallize the optimal stable form and formulate your compound. A controlled crystallization is the preferred isolation method to obtain purified material of a specific polymorphic (salt) form and crystal habit. The solid form determines the stability, ...
  • Drug Discovery and Development of Lipids and small molecule APIs

    Product Drug Discovery and Development of Lipids and small molecule APIs

    Symeres can design, scale-up and manufacture novel lipids and small molecule APIs for wide variety of clients: small biotechs to large Pharma organizations
  • GMP Manufacturing of small molecule APIs

    Product GMP Manufacturing of small molecule APIs

    Symeres can upscale and manufacture novel APIs 

Symeres resources (2)

  • Drug Development

    Brochure Drug Development

    Leverage our 30+ years of experience to design your optimal drug route, with seamless transition to our non-GMP or GMP scale-up units.
  • Symeres Solid-State Center of Excellence

    Video Symeres Solid-State Center of Excellence

    Our Solid-State experts can help you to selectively crystallize the optimal stable form and formulate your compound.

    A controlled crystallization is the preferred isolation method to obtain purified material of a specific polymorphic (salt) form and crystal habit. The solid form determines the stability, solubility and permeability of the compound; therefore, the selection of a pharmaceutically suitable form will manage the risks in further development. The pre-formulation experts study excipient compatibility, pH-dependent solubility and dissolution rate optimization to improve the bioavailability. Symeres has performed hundreds of form characterization and selection screens on innovative APIs throughout the years.
    2024-07-31